SweetValueLab
Write for us

Bio-Techne Corporation — Financial Statements & Ratios

TECH
NASDAQHealthcareBiotechnologyCIK 0000842023bio-techne.comAbout TECH
Last close · Oct 16, 202672.57+0.05 (+0.07%)
Market cap$11.4B

Key indicators

Revenue1.2BFY2026−0.4% on a year earlier+7.9% a year, FY2019–FY2026
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026FY2027EFY2028EFY2029E
Growth
714.0M 738.7M+3.5%931.0M+26.0%1.1B+18.7%1.1B+2.8%1.2B+2.0%1.2B+5.2%1.2B−0.4%1.3B 1.4B 1.6B
— 3.5% 26.0% 18.7% 2.8% 2.0% 5.2% -0.4% 4.5% 10.1% 12.5%
$0.62 $1.46+135.6%$0.87−40.4%$1.66+91.1%$1.76+6.2%$1.05−40.3%$0.46−56.2%$1.16+152.2%$2.03 $2.38 $2.43
Profitability
66.3% 65.4%−0.9 pt68.0%+2.6 pt68.4%+0.5 pt67.7%−0.7 pt66.4%−1.3 pt64.8%−1.6 pt65.8%+1.0 pt· · ·
20.5% 21.3%+0.8 pt25.5%+4.2 pt26.8%+1.3 pt26.3%−0.5 pt17.8%−8.5 pt8.4%−9.4 pt20.7%+12.3 pt· · ·
13.5% 31.0%+17.6 pt15.1%−16.0 pt24.6%+9.5 pt25.1%+0.5 pt14.5%−10.6 pt6.0%−8.5 pt15.0%+8.9 pt· · ·
8.2% 16.6%+8.4 pt9.0%−7.6 pt16.0%+7.0 pt14.5%−1.5 pt8.1%−6.4 pt3.8%−4.3 pt8.6%+4.8 pt· · ·
Cash
156.2M 153.5M−1.8%307.9M+100.6%280.4M−8.9%216.1M−22.9%236.1M+9.2%256.6M+8.7%263.2M+2.6%· · ·
21.9% 20.8%−1.1 pt33.1%+12.3 pt25.4%−7.7 pt19.0%−6.3 pt20.4%+1.4 pt21.0%+0.7 pt21.7%+0.6 pt· · ·
48.4M 48.9M+1.1%49.6M+1.5%50.2M+1.1%50.3M+0.2%50.4M+0.3%50.4M−0.1%49.9M−0.9%· · ·
Balance sheet
0.43x 0.26x−0.18x0.22x−0.04x0.15x−0.07x0.18x+0.03x0.15x−0.02x0.18x+0.03x0.09x−0.09x· · ·
155.57M 157.60M+1.3%161.93M+2.7%164.12M+1.3%161.85M−1.4%160.77M−0.7%159.72M−0.7%157.01M−1.7%· · ·

E = analyst consensus (revenue and EPS only). From the 10-K, as accepted by the SEC; the shaded column is the latest period. EPS and share counts before a stock split are restated in today's share terms.